The intrepid team of cyclists joining Geoff Thomas for his last ever Tour de France and aiming to raise £1,000,000 for Cure Leukaemia has today been revealed.
A team of 20 amateur riders will join former England footballer and blood cancer survivor Geoff, to cycle over 3,400km next June and July, one day before the professionals.
The GT15 event marks 15 years since Geoff, a Patron of Cure Leukaemia, was declared in remission from chronic myeloid leukaemia, and will be his fifth – and last – Tour de France challenge.
It also comes at a crucial stage in Cure Leukaemia’s continuing development and growing influence, with the charity taking on more of a national focus by funding specialist research nurses at 12 different blood cancer centres across the UK from next year.
“With 2020 marking such a landmark anniversary from when I was first told I was in remission, and Cure Leukaemia expanding to become a national charity, it is going to be a massive year for many different reasons,” said Geoff.
“We had a fantastic response to our appeal for riders wanting to join the team; and are today announcing the names of those who are up for such a testing challenge both in completing the course and achieving this fantastic fundraising target for Cure Leukaemia.
Preparations are now well underway - we had our first team meeting last week - and everyone was really enthusiastic and looking forward to what lies ahead.
Click HERE for details of the amateur cyclists who will be joining Geoff for the 21 stages of the Tour from June 26-July 18 2020, with the aim of raising £1,000,000 to impact the lives of leukaemia patients across the UK.
"What this team of people are doing is extraordinary,” said Professor Charlie Craddock CBE, who treated Geoff and is one of the co-founders of Cure Leukaemia.
Their efforts will transform the outcomes for patients; and change the models we are using internationally to treat blood cancer.
The funds raised by GT15 will be invested directly into funding specialist research nurses at 12 centres across the country to form the national Trials Acceleration Programme (TAP) network which Cure Leukaemia will begin funding from January 2020.
Patients from an increased catchment area of over 20 million people will have access, as a result, to potentially life-saving treatments not currently available through standard care.
Today’s team announcement comes shortly after Britain’s leading fine wine merchant Farr Vintners was announced as the headline sponsor for GT15, and other sponsors will be sought in addition to individual riders’ fundraising to try to reach, and hopefully surpass the £1million target.
"Cure Leukaemia is now heading into an exciting new phase in our charity’s history, with the aim of becoming one of the leading players in the treatment of blood cancer and providing as much as support as possible to help the clinicians find a cure,” says Cure Leukaemia CEO James McLaughlin.
It was great to meet some of the riders at the first team meeting last week, and there is a real sense of determination and anticipation to tackle this challenge and raise the funds which will have such a positive impact on the lives of people with blood cancer.
How funds raised for Cure Leukaemia help save lives